期刊文献+

我院静脉药物集中配制管理体系的建立与实施 被引量:6

Establishment and Implementation of the Management System for the Hospital Pharmacy Intravenous Admixture Service(PIVAS)
下载PDF
导出
摘要 目的论述静脉药物集中配制管理的建立与实施。方法静脉药物配置中心(PIVAS)是将原来分散在医院各病区自行配置的静脉滴注药物转为在药学人员监护下集中配置、混合、检查和分发的管理新机构。结果部分解决了不合理用药现象,有利于保障用药安全,促进了医院药学由单纯供应保障型向技术服务型的转变。结论设立PIVAS是医院药学发展和管理的一个重要组成部分。 Objective Focus on the establishment and implementation of the management of intravenous drug admixture. Methods Pharmacy Intravenous Admixture Service (PIVAS) is a new agency which is under the control of pharmacists to concentrate, admixture, check up and distribute the intravenous drugs, compared to the former model of intravenous drugs admixture. Results It has solved the problems of unreasonable drug use, ensured the safety of intravenous drugs use and it has turned the model of the hospital pharmacy from "simply providing" to " pharmaceutical care". It has embodied our notion of "Just for the patients". Conclusi^s PIVAS is an important part of the development and management in hospital phamacy.
出处 《中国药事》 CAS 2009年第6期583-584,606,共3页 Chinese Pharmaceutical Affairs
关键词 静脉药物 配制 PIVAS 质量 管理 intravenous drug admixture PIVAS quality management
  • 相关文献

参考文献5

二级参考文献14

  • 1宋作斌.静脉药物配置中心简介[J].天津护理,2001,9(4):213-214. 被引量:2
  • 2Crawford SY, NaiducciWA, Augustine SC. National survey of quality assurance activities for pharmacy - prepared sterile products in hospitals [J]. Am J Hosp Pharm, 1991, 48( 11 ): 2398 - 413.
  • 3Vogel DP, Eck TA, Witte K. W. Calculation of product waste in Ⅳ Admixture program [J]. AJHP, 1986, 43:952 - 953.
  • 4Paoletti RD, Cerey EW. Reducing costs through centraliazation and standardization of an i. v. admixture program [J]. Am J HealthSyst Pharm, 2000, 57 (12) : 1147 - 1149.
  • 5Hitt CM, Nightingale CH. Cost comparison of single daily i. v. doses of ceftriaxone versus continuous infusion of cefotaxime[J]. Am J Syst Pharm, 1997, 54( 14): 1614- 1618.
  • 6Armour DJ, Caims C J, Costello I, et al. The economics of a pharmacy - based central intravenous additive service for paediatric patients[J]. Pharmacoeconomics, 1996, 10(4): 386- 394.
  • 7Hotchkies L, Grima DT, Hedayati S. The total process cost of parenteral antibiotic therapy: beyond drug acquisition cost [J], Clin Ther, 1996, 18(4): 716 -725.
  • 8Uchida KM, Iteen SA, Wong NT. Identifying costs of intravenous solution wastage [J]. Pharmacoeconomics, 1994, 6(3): 240- 248.
  • 9Milkovich G. Int J Antimicrob Agents [J]. The role of the hospital pharmacist in cost control and antibiotic policy, 2000, 16(3): 291 -294.
  • 10Plumridge RJ, Maher M. Justification of a pharmacy intravenous admixture service in an Australian hospital [J]. Am J Hosp Pharm,.1993, 50(3): 463 -466.

共引文献172

同被引文献23

引证文献6

二级引证文献16

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部